Citations for
1CCL18, NFKB1, PITPNM3
CCL18/PITPNM3 enhances migration, invasion, and EMT through the NF-κB signaling pathway in hepatocellular carcinoma.
Lin Z, Li W, Zhang H, Wu W, Peng Y, Zeng Y, Wan Y, Wang J, Ouyang N.
Tumour Biol 37(3):3461-8. doi: 10.1007/s13277-015-4172-x. 2016
2CCL18
CCL18 promotes epithelial-mesenchymal transition, invasion and migration of pancreatic cancer cells in pancreatic ductal adenocarcinoma.
Meng F, Li W, Li C, Gao Z, Guo K, Song S.
Int J Oncol 46(3):1109-20. doi: 10.3892/ijo.2014.2794. 2015
3CCL18, PITPNM3, PTK2B
Pyk2 and Src mediate signaling to CCL18-induced breast cancer metastasis.
Li HY, Cui XY, Wu W, Yu FY, Yao HR, Liu Q, Song EW, Chen JQ.
J Cell Biochem 115(3):596-603. doi: 10.1002/jcb.24697. 2014
4CCL18, PITPNM3
The Activity of CCL18 is Principally Mediated through Interaction with Glycosaminoglycans.
Krohn S, Garin A, Gabay C, Proudfoot AE.
Front Immunol 4:193. doi: 10.3389/fimmu.2013.00193. 2013
5CCL18
Pulmonary CCL18 recruits human regulatory T cells.
Chenivesse C, Chang Y, Azzaoui I, Ait Yahia S, Morales O, Plé C, Foussat A, Tonnel AB, Delhem N, Yssel H, Vorng H, Wallaert B, Tsicopoulos A.
J Immunol 189(1):128-37. doi: 10.4049/jimmunol.1003616. Epub 2012 May 30. 2012
6CCL18
The chemokine CCL18 causes maturation of cultured monocytes to macrophages in the M2 spectrum.
Schraufstatter IU, Zhao M, Khaldoyanidi SK, Discipio RG.
Immunology 135(4):287-98. doi: 10.1111/j.1365-2567.2011.03541.x. 2012
7CCL18
CCL18 differentiates dendritic cells in tolerogenic cells able to prime regulatory T cells in healthy subjects.
Azzaoui I, Yahia SA, Chang Y, Vorng H, Morales O, Fan Y, Delhem N, Ple C, Tonnel AB, Wallaert B, Tsicopoulos A.
Blood 118(13):3549-58. doi: 10.1182/blood-2011-02-338780. Epub 2011 Jul 29. 2011
8CCL18, PITPNM3
CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3.
Chen J, Yao Y, Gong C, Yu F, Su S, Chen J, Liu B, Deng H, Wang F, Lin L, Yao H, Su F, Anderson KS, Liu Q, Ewen ME, Yao X, Song E.
Cancer Cell 19(4):541-55. doi: 10.1016/j.ccr.2011.02.006. Erratum in: Cancer Cell. 2011 Jun 14;19(6):814-6. 2011
9CCL18, CXCR4
Attenuation of CXCR4 responses by CCL18 in acute lymphocytic leukemia B cells.
Catusse J, Wollner S, Leick M, Schröttner P, Schraufstätter I, Burger M.
J Cell Physiol 225(3):792-800. doi: 10.1002/jcp.22284. 2010
10CCL18
Expression of chemokine (C-C motif) ligand 18 in human macrophages and atherosclerotic plaques.
Hägg DA, Olson FJ, Kjelldahl J, Jernås M, Thelle DS, Carlsson LM, Fagerberg B, Svensson PA.
Atherosclerosis 204(2):e15-20. doi: 10.1016/j.atherosclerosis.2008.10.010. Epub 2008 Nov 1. 2009
11CCL18
Increased expression of CC chemokine ligand 18 in extrinsic atopic dermatitis patients.
Park CO, Lee HJ, Lee JH, Wu WH, Chang NS, Hua L, Lee MG, Lee KH.
Exp Dermatol 17(1):24-9. Epub 2007 Nov 2. 2008
12CCL18
Early cutaneous gene transcription changes in adult atopic dermatitis and potential clinical implications.
Plager DA, Leontovich AA, Henke SA, Davis MD, McEvoy MT, Sciallis GF 2nd, Pittelkow MR.
Exp Dermatol 16(1):28-36. 2007
13CCL3, CCL4, CCL18
Genetic Variation in the CCL18-CCL3-CCL4 Chemokine Gene Cluster Influences HIV Type 1 Transmission and AIDS Disease Progression.
Modi WS, Lautenberger J, An P, Scott K, Goedert JJ, Kirk GD, Buchbinder S, Phair J, Donfield S, O'brien SJ, Winkler C.
Am J Hum Genet 79(1):120-8. Epub 2006 May 30. 2006
14CCL18
Chemokine PARC gene (SCYA18) generated by fusion of two MIP-1alpha/LD78alpha-like genes.
Tasaki Y, et al.
Genomics 55 : 353-357. 1999
15CCL18
Genomic organization and biological characterization of the novel human CC chemokine DC-CK-1/PARC/MIP-4/SCYA18.
Guan P, et al.
Genomics 56(3):296-302. 1999
16CCL18
A novel human CC chemokine PARC that is most homologous to macrophage-inflammatory protein-1 alpha/LD78 alpha and chemotactic for T lymphocytes, but not for monocytes.
Hieshima K, Imai T, Baba M, Shoudai K, Ishizuka K, Nakagawa T, Tsuruta J, Takeya M, Sakaki Y, Takatsuki K, Miura R, Opdenakker G, Van Damme J, Yoshie O, Nomiyama H.
J Immunol 159(3):1140-9. 1997